XML 89 R75.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity - Summary of Employee and Non-Employee Stock Options Activity (Detail) - USD ($)
12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Options, Outstanding (in shares) 366,549    
Options, Granted (in shares) 9,703 0  
Options, Exercised (in shares) 0    
Options, Canceled/forfeited (in shares) (24,244)    
Options, Outstanding (in shares) 352,008 366,549  
Options, Exercisable at March 31, 2016 (in shares) 282,005    
Options, Fully vested and expected to vest at March 31, 2016 (in shares) 347,256    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Weighted-Average Exercise Price, Outstanding (in dollars per share) $ 83.39    
Weighted-Average Exercise Price, Granted (in dollars per share) 6.80    
Weighted-Average Exercise Price, Exercised (in dollars per share) 0.00    
Weighted-Average Exercise Price, Cancelled/Forfeited (in dollars per share) 107.26    
Weighted-Average Exercise Price, Outstanding (in dollars per share) 79.63 $ 83.39  
Weighted-Average Exercise Price, Exercisable at March 31, 2017 (in dollars per share) 96.09    
Weighted-Average Exercise Price, Fully vested and expected to vest at March 31, 2017 (in dollars per share) $ 80.54    
Weighted-Average Remaining Contractual Term, Outstanding at March 31, 2016 5 years 20 days    
Weighted-Average Remaining Contractual Term, Exercisable at March 31, 2016 5 years 8 days    
Weighted-Average Remaining Contractual Term, Fully vested and expected to vest at March 31, 2016 4 years 5 months 20 days    
Aggregate Intrinsic Value, Outstanding at March 31, 2017 $ 600    
Aggregate Intrinsic Value, Exercisable at March 31, 2017 0 $ 0 $ 0
Aggregate Intrinsic Value, Fully vested and expected to vest at March 31, 2017 $ 500